More than one million people in England have been urged to get vaccines for respiratory syncytial virus (RSV), with health ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

The NHS is urging those eligible to get vaccinated against a respiratory illness that can cause pneumonia and lung infections ...

It spreads through inhalation or contact with the fluids from an infected person's coughs or sneezes. 2 While often linked to ...

A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...

Research reveals that even low levels of air pollution significantly increase the risk of respiratory infections in adults, ...

MORE than one million people in England are being urged to get a life-saving new vaccine. It protects against respiratory syncytial virus (RSV) – a cold-like illness that can make some ...

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

The NHS rolled out the first ever routine vaccination programme this winter, with estimates suggesting it could prevent up to ...

Outpatient health care visits for flu-like illnesses are at their highest levels in 15 years, according to data updated ...

It appears RSV and COVID have peaked, but the flu is still rising. The number and rate of positive cases of COVID is notably ...

A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.